References
- Ahmad S, Shoaib A, Ali S, et al. Epidemiology, risk, myths, pharmacotherapeutic management and socio economic burden due to novel COVID-19: a recent update. Res J Pharm Technol. 2020;13(9):4435–4442.
- Yasuhara J, Kuno T, Takagi H, et al. Clinical characteristics of COVID‐19 in children: a systematic review. Pediatr Pulmonol. 2020;55:2565–2575.
- Fajnzylber J, Regan J, Coxen K, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020;11:1–9.
- Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767–783.
- Song Y, Liu P, Shi XL, et al. SARS-CoV-2 induced diarrhea as onset symptom in patient with COVID-19. Gut. 2020;69:1143–1144.
- Spinato G, Fabbris C, Polesel J, et al. Alterations in smell or taste in mildly symptomatic outpatients with SARS-CoV-2 infection. JAMA. 2020;323:2089–2090.
- Yang W, Sirajuddin A, Zhang X, et al. The role of imaging in 2019 novel coronavirus pneumonia (COVID-19). Eur Radiol. 2020;30:4874–4882.
- Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): relationship to duration of infection. Radiology. 2020;295:685–691.
- Yoon SH, Lee KH, Kim JY, et al. Chest radiographic and CT findings of the 2019 novel coronavirus disease (COVID-19): analysis of nine patients treated in Korea. Korean J Radiol. 2020;21:494–500.
- Ahmad T, Khan M, Musa TH, et al. COVID-19: zoonotic aspects. Travel Med Infect Dis. 2020;36:101607.
- Michelen M, Manoharan L, Elkheir N, et al. Characterising long-term covid-19: a rapid living systematic review. medRxiv. 2020. DOI:10.1101/2020.12.08.20246025.
- Zheng YY, Ma YT, Zhang JY, et al. and the cardiovascular system. Nat Rev Cardiol. 2020;17:259–260.
- Bao L, Deng W, Huang B, et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020;583:830–833.
- Chandrashekar A, Liu J, Martinot AJ, et al. SARS-CoV-2 infection protects against rechallenge in rhesus macaques. Science. 2020;369:812–817.
- Imai M, Iwatsuki-Horimoto K, Hatta M, et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. PNAS. 2020;117:16587–16595.
- Melin AD, Janiak MC, Marrone F, et al. Comparative ACE2 variation and primate COVID-19 risk. BioRxiv. 2020. DOI:10.1101/2020.04.09.034967
- Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2. Science. 2020;368:1016–1020.
- Chen W. Promise and challenges in the development of COVID-19 vaccines. Human Vacc Immunother. 2020;16:2604–2608.
- Lakdawala SS, Menachery VD. The search for a COVID-19 animal model. Science. 2020;368:942–943.
- Pandey K, Acharya A, Mohan M, et al. Animal Models for SARS‐CoV‐2 research: a comprehensive literature review. Transbound Emerg Dis. 2020. DOI:10.1111/tbed.13907
- Sia SF, Yan LM, Chin AWH, et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature. 2020;583:834–838.
- Ulrich L, Wernike K, Hoffmann D, et al. Experimental infection of cattle with SARS-CoV-2. Emerg Infect Dis. 2020;26:2979.
- McCray PB Jr, Pewe L, Wohlford-Lenane C, et al. Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus. J Virol. 2007;81:813–821.
- Chung HJ, Kim HJ, Hong ST. Iron-dextran as a thermosensitizer in radiofrequency hyperthermia for cancer treatment. Appl Biol Chem. 2019;62:1–9.
- Chung HJ, Lee HK, Kwon KB, et al. Transferrin as a thermosensitizer in radiofrequency hyperthermia for cancer treatment. Sci Rep. 2018;8:1–11.
- Hassan MM, Sharmin S, Kim HJ, et al. Identification and characterization of plasmin-independent thrombolytic enzymes. Circ Res. 2021;128:386–400.
- Kłopot A, Zakrzewska A, Lecion D, et al. Real-time qPCR as a method for detection of antibody-neutralized phage particles. Front Microbiol. 2017;8:2170.
- Chung HJ, Sharma SP, Kim HJ, et al. The resveratrol-enriched rice DJ526 boosts motor coordination and physical strength. Sci Rep. 2016;6:23958.
- Chung HJ, Chen X, Yu Y, et al. A critical role of hepatitis B virus polymerase in cirrhosis, hepatocellular carcinoma, and steatosis. FEBS Open Bio. 2018;8:130–145.
- Nagpal P, Narayanasamy S, Vidholia A, et al. Imaging of COVID-19 pneumonia: patterns, pathogenesis, and advances. Br J Radiol. 2020;93:20200538.
- Rousan LA, Elobeid E, Karrar M, et al. Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulm Med. 2020;20:1–9.
- Zantah M, Castillo ED, Townsend R, et al. Pneumothorax in COVID-19 disease-incidence and clinical characteristics. Respir Res. 2020;21:1–9.
- Hassan SA, Sheikh FN, Jamal S, et al. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 2020;12:7355–7362.
- Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16:e1008536.
- Gu SX, Tyagi T, Jain K, et al. Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation. Nat Rev Cardiol. 2020;19:1–16.
- Merrill JT, Erkan D, Winakur J, et al. Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nat Rev Rheumatol. 2020;16:581–589.
- Rapkiewicz AV, Mai X, Carsons SE, et al. Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: a case series. EClinicalMedicine. 2020;24:100434.
- Eljilany I, Elzouki AN. D-Dimer, Fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vasc Health Risk Manag. 2020;16:455.
- Srivastava S, Garg I, Bansal A, et al. infection and Thrombosis. Clin Chim Acta. 2020;510:344–346.
- Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020;5:428–430.
- Xu L, Liu J, Lu M, et al. Liver injury during highly pathogenic human coronavirus infections. Liver Int. 2020;40:998–1004.
- Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell. 2020;183:16–27.
- Matschke J, Lütgehetmann M, Hagel C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19:919–929.
- Bhatnagar J, Gary J, Reagan-Steiner S, et al. Evidence of severe acute respiratory syndrome coronavirus 2 replication and tropism in the lungs, airways, and vascular endothelium of patients with fatal coronavirus disease 2019: an autopsy case series. J Infect Dis. 2021;223(5):752–764.
- Heegaard PM, Sturek M, Alloosh M, et al. Animal models for COVID-19: more to the picture than ACE2, rodents, ferrets, and non-human primates. a case for porcine respiratory coronavirus and the obese ossabaw pig. Front Microbiol. 2020;11:2333.
- Muñoz-Fontela C, Dowling WE, Funnell SGP, et al. Animal models for COVID-19. Nature. 2020;586:509–515.
- Trimpert J, Vladimirova D, Dietert K, et al. The Roborovski Dwarf hamster is a highly susceptible model for a rapid and fatal course of SARS-CoV-2 infection. Cell Rep. 2020;33:108488.
- Dorp L, Acman M, Richard D, et al. Emergence of genomic diversity and recurrent mutations in SARS-CoV-2. Infect Genet Evol. 2020;83:104351.